A61K 2039/106
Vibrio
Official title: {Vibrio; Campylobacter; Not used, see subgroups}
A61K2039/106 (Vibrio) appears on 5 US grants and 10 published applications in this corpus.
Search patents in A61K- Granted patents
- 5
- Published applications
- 10
- Assignees
- 7
- Inventors
- 17
- Latest grant
- 11 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 1 | 2 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 2 | 2 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Lactococcus lactis subspecies lactis isolate WFLU-12 and use thereof11 Jun 2024US 12,005,108 B2Pukyong National University Industry-University Cooperation Foundation
- Preparation of live vaccines20 Feb 2024US 11,904,008 B2Elanco Tiergesundheit AG
- Recombinant gram negative bacteria and methods of generating and utilizing same3 Aug 2021US 11,078,257 B2The Regents of the University of Michigan
- Preparation of live vaccines10 Nov 2020US 10,828,362 B2Elanco Tiergesundheit AG
- Campylobacter vaccine16 Apr 2019US 10,258,680 B2The Governors of the University of Alberta
- Preparation of live vaccines5 Jun 2025US 2025/0177508 A1Elanco Tiergesundheit AG
- Composition for rearing organism belonging to order decapoda and composition for preventing or treating infection in decapods10 Oct 2024US 2024/0335486 A1Sumitomo Chemical Company, Limited
- Preparation of live vaccines6 Jun 2024US 2024/0181031 A1Elanco Tiergesundheit AG
- Novel lactococcus lactis subspecies lactis isolate wflu-12 and use thereof27 Jul 2023US 2023/0235276 A1Pukyong National University Industry-University Cooperation Foundation
- Preparation of live vaccines24 Mar 2022US 2022/0088168 A1Elanco Tiergesundheit AG
Most cited
By later US patents